As the price of bitcoin rallies above $100,000, a host of companies are harnessing public markets via SPACs and reverse mergers to purchase digital assets en masse. (Illustration: Philip Smith for Forbes) https://t.co/TA0luLESCV https://t.co/oHVWBBxXAc ...

Core Points - A federal judge in California granted preliminary approval for a $38 million cash settlement between several pension funds and Bayer AG to resolve a securities class action lawsuit [1] - The lawsuit, originally filed in 2020, relates to Bayer's acquisition of Monsanto in 2018 and allegations of misleading statements regarding the risks associated with Roundup, a glyphosate-based herbicide [2] - The settlement aims to provide closure to a significant case concerning the adequacy of disclosures in corporate mergers and reaffirms the rights of investors purchasing American Depositary Receipts (ADRs) under U.S. securities laws [3] Legal Proceedings - The case has involved nearly five years of litigation, with a focus on the transparency of disclosures related to due diligence in high-profile mergers [3] - In May 2023, the court granted class certification, appointing specific pension funds as class representatives and affirming the rights of ADR purchasers in the over-the-counter market [5] - The discovery process was complex, requiring international cooperation and legal proceedings under the Hague Convention to obtain testimony from Bayer's former general counsel in Germany [6] Implications for Investors - The settlement is seen as a significant resolution for investors in publicly traded foreign companies, ensuring accountability under U.S. securities laws [4] - The case highlights the enforceable rights of ADR investors, particularly in light of the court's ruling on the extraterritoriality issue [5]

Genius Act. We know all the things we're talking about. I think JP morgan's going to be right there.>> All right. For more on the strength in banks, I had a stress test in the start of earnings season. Let's bring in RBC Capital Markets.Co-Head of Global financials Research Gerard Cassidy. Gerard, great to see you. Are you expecting any surprises tomorrow.>> We're really not. I think tomorrow we should all expect is that the banks will all pass and flying colors like they have for a number of years of, you ...

Japan's newfound openness to hostile M&A risk seeding and indispensibility to global supply chains that has been carefully built up over decades. Analysts say hostile bids pose both a threat and an opportunity for Japan's government, which views M&A as a way to encourage consolidation in fragmented industries, shake up complacent boardrooms, and improve corporate governance. But some Japanese officials are rushing to prevent the nation losing control over its most advanced and sensitive technologies.Industr ...

Glacier Bancorp (GBCI) M&A Announcement June 25, 2025 09:00 AM ET Speaker0 Good day and thank you for standing by. Welcome to the Glacier Bancorp Investor Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Randy Chesler, President and CEO of Glacier Bancorp. Please go ahead. Speaker1 All ri ...

Group 1 - Phibro Animal Health (NASDAQ: PAHC) announced a significant acquisition from Zoetis (ZTS) aimed at driving business momentum [1] - The investment group "Value In Corporate Events" focuses on identifying opportunities in IPOs, mergers & acquisitions, earnings reports, and corporate capital allocation [1] - The service covers approximately 10 major events monthly to find optimal investment opportunities [1]

Singapore, June 24, 2025 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (Nasdaq: WBUY) (Webuy or the “Company”), a leading community e-commerce and travel platform in Southeast Asia, previously announced via Form 6-K the appointment of Mr. Heng Wee Koon as Independent Director and Chair of the Compensation Committee. The Company now takes the opportunity to highlight Mr. Heng’s distinguished credentials and the strategic value he brings to the Company. Mr. Heng brings over 25 years of leadership experience spanning ...

A bidding war appears to be brewing for building products distribution company GMS (GMS 24.74%), and investors are excited by the possibilities.Shares of GMS jumped 26% on Friday morning after the company was put in play by an unsolicited suitor. A building products bidding war?GMS is a construction products distributor and tool supplier for consumer and commercial customers. Late Wednesday, QXO (QXO 5.29%) proposed acquiring the business for about $5 billion, or $95.20 per share in cash, a premium of 27% t ...

Key Takeaways LLY will acquire Verve to add in vivo gene therapies for heart disease, including VERVE-102. Gene-editing stocks like CRSP, NTLA, and BEAM rose after the LLY-Verve deal was announced. 2025 has seen a resurgence in mergers and acquisitions targeting gene editing and rare diseases. Eli Lilly’s (LLY) recent announcement to acquire Verve Therapeutics, Inc (VERV) , a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, has put the spotlight on other promisi ...

Castlelake, owner of a 79% stake in AEDAS, has signed an irrevocable agreement to sell its stake to Neinor for €24.485/sh (€21.335/sh post div.) Acquisition of a premium portfolio with c.€2bn GAV (c.20,200#) at a c.30% NAV discount Conservative underwriting targeting a +20% IRR and 1.8x MOIC, implying significant de-risking and acceleration of Neinor’s Strategic Plan 2023-27: Highly accretive transaction, driving €150mn Earnings uplift over 2025-27 (+40% vs Strategic Plan target and c.+25% on EPS), and ...